Literature DB >> 22462796

Clinical and imaging overview of functional adrenal neoplasms.

Gavin Low1, Kamal Sahi.   

Abstract

Adrenal adenoma, adrenocortical carcinoma, pheochromocytoma and neuroblastoma are four discrete adrenal neoplasms that have the potential for functional activity. Functional adrenal neoplasms can secrete cortisol, aldosterone, sex hormones or catecholamines. These heterogeneous groups of tumors show varied biological behavior and clinical outcomes. These neoplasms are encountered with increasing clinical frequency as a result of an expansion in the volume of medical imaging carried out. The clinical presentation, including prognosis and treatment options, and the imaging features of these neoplasms are discussed. The key radiological observations of each of these neoplasms are shown using multimodality images. Familiarity with the clinical and imaging features of these neoplasms improves diagnosis, and facilitates appropriate clinical decision-making and patient management.
© 2012 The Japanese Urological Association.

Entities:  

Mesh:

Year:  2012        PMID: 22462796     DOI: 10.1111/j.1442-2042.2012.03014.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  11 in total

1.  Challenge in preoperative diagnosis of retroperitoneal mucinous cyst in a pediatric patient.

Authors:  Deying Zhang; Yan Zhang; Xing Liu; Jin Zhu; Chuan Feng; Chunjiang Yang; Shengde Wu; Junhong Liu; Yi Hua; Feng Liu; Nan Zhang; Yuanyuan Zhang; Dawei He; Tao Lin; Guanghui Wei
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Largest pheochromocytoma reported in Canada: A case study and literature review.

Authors:  Druvtej Ambati; Kunal Jana; Trustin Domes
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

3.  The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.

Authors:  Hyun Jung Koo; Hyuck Jae Choi; Hwa Jung Kim; Sun-Ok Kim; Kyoung-Sik Cho
Journal:  Eur Radiol       Date:  2014-03-20       Impact factor: 5.315

4.  Case Report: A giant but silent adrenal pheochromocytoma - a rare entity.

Authors:  Sunil Munakomi; Saroj Rajbanshi; Prof Shailesh Adhikary
Journal:  F1000Res       Date:  2016-03-07

5.  Diagnostic and surgical challenges of a giant pheochromocytoma in a resource limited setting-A case report.

Authors:  David Muchuweti; Edwin G Muguti; Bothwell A Mbuwayesango; Simbarashe Gift Mungazi; Rudo Makunike-Mutasa
Journal:  Int J Surg Case Rep       Date:  2018-08-01

6.  Neuroendocrine tumor of the kidney: Diagnostic challenge and successful therapy.

Authors:  Jamal Zekri; Haleem Jawed Rasool; Abdelrazak Meliti; Jawairiya Rasool
Journal:  Urol Ann       Date:  2019 Oct-Dec

7.  Identification of novel neuroblastoma biomarkers in urine samples.

Authors:  Kazuki Yokota; Hiroo Uchida; Minoru Sakairi; Mayumi Abe; Yujiro Tanaka; Takahisa Tainaka; Chiyoe Shirota; Wataru Sumida; Kazuo Oshima; Satoshi Makita; Hizuru Amano; Akinari Hinoki
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 8.  Open versus minimally invasive surgery for suspected adrenocortical carcinoma.

Authors:  Dylan M Buller; Alex M Hennessey; Benjamin T Ristau
Journal:  Transl Androl Urol       Date:  2021-05

9.  Rare myeloid sarcoma/acute myeloid leukemia with adrenal mass after allogeneic mobilization peripheral blood stem cell transplantation.

Authors:  Ya-Fei Wang; Qian Li; Wen-Gui Xu; Jian-Yu Xiao; Qing-Song Pang; Qing Yang; Yi-Zuo Zhang
Journal:  Cancer Biol Med       Date:  2013-12       Impact factor: 4.248

10.  Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors.

Authors:  Helene Myrtue Nielsen; Alexandre How-Kit; Carole Guerin; Frederic Castinetti; Hans Kristian Moen Vollan; Catherine De Micco; Antoine Daunay; David Taieb; Peter Van Loo; Celine Besse; Vessela N Kristensen; Lise Lotte Hansen; Anne Barlier; Frederic Sebag; Jörg Tost
Journal:  Endocr Relat Cancer       Date:  2015-09-23       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.